Folate transporter offers clues for anticancer drugs – Nature.com
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Advertisement
Larry H. Matherly is at the Karmanos Cancer Institute and Wayne State University, Detroit, Michigan 48201, USA.
You can also search for this author in PubMed Google Scholar
Zhanjun Hou is at the Karmanos Cancer Institute and Wayne State University, Detroit, Michigan 48201, USA.
You can also search for this author in PubMed Google Scholar
The transport protein SLC19A1, better known as the reduced folate carrier, resides in the cell membrane. It has been studied for decades because it is the main tissue transporter of the B9 vitamins (called folates), which are required for reactions needed to make certain types of nucleotide and to make the amino-acid residues serine and methionine1. SLC19A1 also happens to be the main transporter of the drugs methotrexate and pemetrexed — which are called antifolates, because they block the action of folates. These drugs are used in the treatment of cancer, rheumatoid arthritis and psoriasis1. In 2019, a new role for SLC19A1 was identified, as a transporter of signalling molecules called cyclic dinucleotides (CDNs), which stimulate a wide range of immune-system cellular responses2,3.
Subscribe to Nature+
Get immediate online access to Nature and 55 other Nature journal
$29.99
monthly
Subscribe to Journal
Get full journal access for 1 year
$199.00
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
doi: https://doi.org/10.1038/d41586-022-03767-5
Matherly, L. H., Hou, Z. & Deng, Y. Cancer Metast. Rev. 26, 111–128 (2007).
Article Google Scholar
Luteijn, R. D. et al. Nature 573, 434–438 (2019).
Article PubMed Google Scholar
Ritchie, C., Cordova, A. F., Hess, G. T., Bassik, M. C. & Li, L. Mol. Cell 75, 372–381 (2019).
Article PubMed Google Scholar
Zhang, Q. et al. Nature https://doi.org/10.1038/s41586-022-05452-z (2022).
Article Google Scholar
Wright, N. J. et al. Nature 609, 1056–1062 (2022).
Article Google Scholar
Hopfner, K.-P. & Hornung, V. Nature Rev. Mol. Cell Biol. 21, 501–521 (2020).
Article PubMed Google Scholar
Demaria, O. et al. Proc. Natl Acad. Sci. USA 112, 15408–15413 (2015).
Article PubMed Google Scholar
Qiu, A. et al. Cell 127, 917–928 (2006).
Article PubMed Google Scholar
Matherly, L. H., Schneider, M., Gangjee, A. & Hou, Z. Expert Opin. Drug Metab. Toxicol. 18, 695–706 (2022).
Article PubMed Google Scholar
Parker, J. L. et al. Nature 595, 130–134 (2021).
Article PubMed Google Scholar
Download references
The authors declare no competing interests.
Read the paper: Recognition of cyclic dinucleotides and folates by human SLC19A1
cGAS-like receptors put a sting into the evolution of immune defence
A toxin that fuels metabolism
See all News & Views
Uncoordinated protein coordinates cell migration
News & Views
AlphaFold’s new rival? Meta AI predicts shape of 600 million proteins
News
Cryo-EM structure of the SEA complex
Article
Uncoordinated protein coordinates cell migration
News & Views
Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer
Article
A spatial perspective on bacteria in tumours
News & Views
A spatiotemporally resolved single-cell atlas of the Plasmodium liver stage
Article
The shape-shifting blobs that shook up cell biology
News Feature
Blocking PD-L1–PD-1 improves senescence surveillance and ageing phenotypes
Article
University of Maryland, Baltimore County (UMBC)
Baltimore, MD, MD, United States
University of Illinois at Chicago (UIC)
Chicago, IL, United States
University of Toronto (U of T)
Toronto, Ontario, Canada
University of Ottawa (uOttawa)
Ottawa, Ontario, Canada
Read the paper: Recognition of cyclic dinucleotides and folates by human SLC19A1
cGAS-like receptors put a sting into the evolution of immune defence
A toxin that fuels metabolism
See all News & Views
An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.
Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.
© 2022 Springer Nature Limited